Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.13 USD | +3.73% | +1.25% | +29.20% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.20% | 1.96B | |
+53.93% | 55.7B | |
+41.08% | 39.91B | |
-5.72% | 39.57B | |
-5.56% | 28.16B | |
+16.41% | 26.3B | |
-20.14% | 18.94B | |
+32.87% | 12.17B | |
+26.88% | 12.12B | |
+2.18% | 12.12B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Piper Sandler Raises Price Target on Kymera Therapeutics to $56 From $39, Maintains Overweight Rating